Table 3.
Res | Nr | WAS | Res | Nr | WAS | ||
---|---|---|---|---|---|---|---|
A | |||||||
GLY | 21 | A | 11 | LYS | 19 | B | 6 |
ARG | 52 | A | 33 | ALA | 20 | B | 54 |
PHE | 53 | A | 28 | GLY | 21 | B | 53 |
ARG | 67 | A | 15 | LEU | 22 | B | 8 |
ASP | 69 | A | 20 | PRO | 25 | B | 54 |
SER | 89 | A | 4 | HIS | 51 | B | 4 |
GLU | 90 | A | 2 | ARG | 52 | B | 59 |
LYS | 92 | A | 53 | PHE | 53 | B | 57 |
TYR | 94 | A | 42 | VAL | 106 | B | 6 |
LYS | 105 | A | 64 | PHE | 108 | B | 27 |
SER | 107 | A | 1 | PHE | 109 | B | 83 |
PHE | 108 | A | 10 | PRO | 111 | B | 73 |
PHE | 109 | A | 89 | PHE | 112 | B | 138 |
GLY | 110 | A | 40 | TYR | 113 | B | 36 |
PRO | 111 | A | 84 | GLY | 114 | B | 24 |
PHE | 112 | A | 100 | PRO | 133 | B | 37 |
TYR | 113 | A | 85 | ASP | 134 | B | 43 |
GLY | 114 | A | 13 | ASP | 136 | B | 7 |
PRO | 133 | A | 28 | TYR | 137 | B | 51 |
ASP | 134 | A | 18 | TRP | 139 | B | 3 |
TYR | 137 | A | 46 | Total | 823 | ||
Total | 786 |
Nr | WAS | ||
---|---|---|---|
B | |||
HIS | 51 | B | 9 |
ARG | 52 | B | 9 |
PHE | 53 | B | 51 |
GLU | 54 | B | 4 |
ASN | 76 | B | 13 |
SER | 89 | B | 20 |
VAL | 106 | B | 2 |
PHE | 108 | B | 43 |
PHE | 109 | B | 19 |
GLY | 114 | B | 1 |
Total | B | 171 | |
ARG | 52 | A | 40 |
PHE | 53 | A | 2 |
PHE | 109 | A | 16 |
PRO | 111 | A | 10 |
PHE | 112 | A | 21 |
Total | A | 89 |
The columns A and B refer to the Blc monomer involved in the interaction B.